Your shopping cart is currently empty

DBCO-PEG4-VC-PAB-MMAE is a drug-linker complex consisting of an ADC linker (DBCO-PEG4-VC-PAB) and the tubulin polymerization inhibitor MMAE. It is a key building block utilized for the synthesis of antibody-drug conjugates (ADCs). MMAE, a synthetic derivative of dolastatin 10, functions as a potent mitotic inhibitor by blocking tubulin polymerization. The reagent features a DBCO group, enabling strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules via click chemistry. The VC-PAB (Valine-Citrulline-p-aminobenzylcarbamate) moiety is a Cathepsin B-cleavable linker, ensuring site-specific drug release within the lysosomal environment of target cells.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $145 | - | In Stock | |
| 5 mg | $362 | - | In Stock |
| Description | DBCO-PEG4-VC-PAB-MMAE is a drug-linker complex consisting of an ADC linker (DBCO-PEG4-VC-PAB) and the tubulin polymerization inhibitor MMAE. It is a key building block utilized for the synthesis of antibody-drug conjugates (ADCs). MMAE, a synthetic derivative of dolastatin 10, functions as a potent mitotic inhibitor by blocking tubulin polymerization. The reagent features a DBCO group, enabling strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules via click chemistry. The VC-PAB (Valine-Citrulline-p-aminobenzylcarbamate) moiety is a Cathepsin B-cleavable linker, ensuring site-specific drug release within the lysosomal environment of target cells. |
| Molecular Weight | 1658.06 |
| Formula | C88H128N12O19 |
| Cas No. | 2129164-91-4 |
| Smiles | C(CCC(NCCOCCOCCOCCOCCC(N[C@H](C(N[C@H](C(NC1=CC=C(COC(N([C@H](C(N[C@H](C(N([C@H]([C@@H](CC(=O)N2[C@]([C@@H]([C@H](C(N[C@@H]([C@@H](O)C3=CC=CC=C3)C)=O)C)OC)(CCC2)[H])OC)[C@H](CC)C)C)=O)[C@H](C)C)=O)C(C)C)C)=O)C=C1)=O)CCCNC(N)=O)=O)[C@@H](C)C)=O)=O)(=O)N4C=5C(C#CC=6C(C4)=CC=CC6)=CC=CC5 |
| Relative Density. | 1.25 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120.00 mg/mL (72.37 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.